Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
for developing and optimizing plasma-based functionalization processes for ferrimagnetic nanoparticles. The successful candidate will be responsible for investigating the relationships between plasma parameters
-
control over the structure of the nanoparticles. For that purpose, temperature is a decisive external parameter driving the structure both during synthesis and during many practical uses, including cancer
-
biomedical applications. The “Polymers and Peptide-Based Materials” group develops bottom-up approaches to incorporate functional peptides into polymers, hydrogels, nanoparticles, and hybrid materials
-
Laboratory of Oceanography of Villefranche | Villefranche sur Mer, Provence Alpes Cote d Azur | France | 19 days ago
of the instrumental preparation (experimental set-up and mass spectrometer calibrations), actively participate to the field campaign, analyze and interpret the nanoparticle fluxes and properties. Where
-
research topics include Langmuir films mimicking cell membranes, the assembly of nanoparticles at liquid interfaces, and catalysis (CVD growth of 2D materials on LMCat, and Fischer–Tropsch synthesis
-
-reinforced polymer composites and multifunctional composite materials. Incorporation of fillers, fibres, nanoparticles or other functional phases to tailor material properties. Investigation of polymer–filler
-
of functional luminescent layers. The recruited postdoctoral researcher will contribute to the development of advanced functional inks incorporating luminescent nanoparticles and to their deposition through
-
. - activities: • Synthesis of non-noble metal-based catalysts (e.g., doped metal oxide nanoparticles) • Physico-chemical and electrochemical characterization of nanocatalysts
-
). - Develop mitigation strategies or transform embrittlement into a green synthesis route for advanced nanocatalysts. Missions and activities: - Synthesize model metal micro/nanoparticles (Pt, Ag, Au, Cu, Ni
-
immunotherapy interventions targeting CD4+ T cells based on recombinant monoclonal antibodies or mRNA-containing lipid nanoparticles. The project will be primarily developed in a pre-clinical murine model of lung